BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 6.08.1998

Draft Modifications To Devices Subject To Premarket ApprovalThe PMA Supplement Decision Making Process; Availability

The Food and Drug Administration (FDA) is announcing the availability of the draft guidance entitled ``Modifications To Devices Subject To Premarket Approval--The PMA Supplement Decision Making Process.'' This draft guidance is neither final nor is it in effect at this time. The draft guidance includes a flowchart model that could be used by premarket approval application (PMA) holders in their decisionmaking to analyze whether certain changes in a device affect the safety or effectiveness of the device, and therefore, require submission of a new PMA, PMA supplement, alternate submission to a PMA supplement, annual report or documentation in the PMA holders' files on the device.

Source: Federal Register — Food and Drug AdministrationOpen original release →